innovative therapeutics
Clicks: 234
ID: 186145
2016
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Popular Article
64.3
/100
232 views
188 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Natriuretic peptides (NPs) are essential for the maintenance of volume homeostasis, and can be of myocardial, renal, and endothelial origin. Advances in peptide engineering have enabled the design of innovative designer NPs that go beyond native peptides in efficacy, specificity, and resistance to enzymatic degradation. Therefore, designer NPs provide an unparalleled opportunity for the treatment of cardiovascular disease. In this review, we report the conceptual framework of peptide engineering of the NPs that resulted in designer peptides for cardiovascular disease. We specifically provide an update on those currently in clinical trials for heart failure and hypertension.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (96 words).
Try re-searching for a better abstract.
| Reference Key |
phd2016jacc:innovative
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Laura M.G. Meems, MD, PhD;John C. Burnett, Jr., MD |
| Journal | journal of nuclear materials |
| Year | 2016 |
| DOI |
10.1016/j.jacbts.2016.10.001
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.